|
WDR43 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.752500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.352800E-01 |
| Normal-vs-Stage2 |
3.552000E-01 |
| Normal-vs-Stage3 |
4.254200E-02 |
| Normal-vs-Stage4 |
9.421800E-02 |
| Stage1-vs-Stage2 |
4.191800E-01 |
| Stage1-vs-Stage3 |
6.415700E-02 |
| Stage1-vs-Stage4 |
1.135160E-01 |
| Stage2-vs-Stage3 |
3.516800E-01 |
| Stage2-vs-Stage4 |
1.875410E-01 |
| Stage3-vs-Stage4 |
5.959000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.080620E-01 |
| Normal-vs-AfricanAmerican |
3.916000E-01 |
| Normal-vs-Asian |
3.030200E-01 |
| Caucasian-vs-AfricanAmerican |
7.574600E-01 |
| Caucasian-vs-Asian |
1.662840E-01 |
| AfricanAmerican-vs-Asian |
3.772000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.588200E-01 |
| Normal-vs-Female |
3.243300E-04 |
| Male-vs-Female |
9.776000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.463600E-01 |
| Normal-vs-Extreme_Weight |
5.126800E-01 |
| Normal-vs-Obese |
2.414500E-02 |
| Normal-vs-Extreme_Obese |
9.452800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.137000E-01 |
| Normal_Weight-vs-Obese |
1.700020E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.484600E-01 |
| Extreme_Weight-vs-Obese |
1.062070E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.192800E-01 |
| Obese-vs-Extreme_Obese |
3.492000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.232010E-02 |
| Normal-vs-Age(41-60Yrs) |
3.771600E-02 |
| Normal-vs-Age(61-80Yrs) |
5.826200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.323710E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.105600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.639860E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.898800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.810810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.622570E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.797830E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.943000E-01 |
| Normal-VS-Type2 PRCC |
2.018200E-01 |
| Normal-VS-KIRP CIMP |
7.081300E-03 |
| Normal-VS-Unclassified PRCC |
8.210500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.297400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.297500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.343800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.227730E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.134000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.727640E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.807800E-01 |
| Normal-vs-N1 |
1.342780E-03 |
| Normal-vs-N2 |
3.767200E-01 |
| N0-vs-N1 |
1.081710E-03 |
| N0-vs-N2 |
1.667050E-01 |
| N1-vs-N2 |
3.848400E-01 |
|
|
